A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Baylor College of Medicine
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Seagen Inc.
Medical College of Wisconsin
National Institutes of Health Clinical Center (CC)